Cargando…

WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M

BACKGROUND: Bone loss is often observed adjacent to inflammatory processes. The WNT signaling pathways have been implicated as novel regulators of both immune responses and bone metabolism. WNT16 is important for cortical bone mass by inhibiting osteoclast differentiation, and we have here investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Henning, Petra, Movérare-Skrtic, Sofia, Westerlund, Anna, Chaves de Souza, Pedro Paulo, Floriano-Marcelino, Thais, Nilsson, Karin H, El Shahawy, Maha, Ohlsson, Claes, Lerner, Ulf H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457865/
https://www.ncbi.nlm.nih.gov/pubmed/34566421
http://dx.doi.org/10.2147/JIR.S323435
_version_ 1784571195664891904
author Henning, Petra
Movérare-Skrtic, Sofia
Westerlund, Anna
Chaves de Souza, Pedro Paulo
Floriano-Marcelino, Thais
Nilsson, Karin H
El Shahawy, Maha
Ohlsson, Claes
Lerner, Ulf H
author_facet Henning, Petra
Movérare-Skrtic, Sofia
Westerlund, Anna
Chaves de Souza, Pedro Paulo
Floriano-Marcelino, Thais
Nilsson, Karin H
El Shahawy, Maha
Ohlsson, Claes
Lerner, Ulf H
author_sort Henning, Petra
collection PubMed
description BACKGROUND: Bone loss is often observed adjacent to inflammatory processes. The WNT signaling pathways have been implicated as novel regulators of both immune responses and bone metabolism. WNT16 is important for cortical bone mass by inhibiting osteoclast differentiation, and we have here investigated the regulation of WNT16 by several members of the pro-inflammatory gp130 cytokine family. METHODS: The expression and regulation of Wnt16 in primary murine cells were studied by qPCR, scRNAseq and in situ hybridization. Signaling pathways were studied by siRNA silencing. The importance of oncostatin M (OSM)-induced WNT16 expression for osteoclastogenesis was studied in cells from Wnt16-deficient and wild-type mice. RESULTS: We found that IL-6/sIL-6R and OSM induce the expression of Wnt16 in primary mouse calvarial osteoblasts, with OSM being the most robust stimulator. The induction of Wnt16 by OSM was dependent on gp130 and OSM receptor (OSMR), and downstream signaling by the SHC1/STAT3 pathway, but independent of ERK. Stimulation of the calvarial cells with OSM resulted in enhanced numbers of mature, oversized osteoclasts when cells were isolated from Wnt16 deficient mice compared to cells from wild-type mice. OSM did not affect Wnt16 mRNA expression in bone marrow cell cultures, explained by the finding that Wnt16 and Osmr are expressed in distinctly different cells in bone marrow, nor was osteoclast differentiation different in OSM-stimulated bone marrow cell cultures isolated from Wnt16(−/-) or wild-type mice. Furthermore, we found that Wnt16 expression is substantially lower in cells from bone marrow compared to calvarial osteoblasts. CONCLUSION: These findings demonstrate that OSM is a robust stimulator of Wnt16 mRNA in calvarial osteoblasts and that WNT16 acts as a negative feedback regulator of OSM-induced osteoclast formation in the calvarial bone cells, but not in the bone marrow.
format Online
Article
Text
id pubmed-8457865
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84578652021-09-23 WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M Henning, Petra Movérare-Skrtic, Sofia Westerlund, Anna Chaves de Souza, Pedro Paulo Floriano-Marcelino, Thais Nilsson, Karin H El Shahawy, Maha Ohlsson, Claes Lerner, Ulf H J Inflamm Res Original Research BACKGROUND: Bone loss is often observed adjacent to inflammatory processes. The WNT signaling pathways have been implicated as novel regulators of both immune responses and bone metabolism. WNT16 is important for cortical bone mass by inhibiting osteoclast differentiation, and we have here investigated the regulation of WNT16 by several members of the pro-inflammatory gp130 cytokine family. METHODS: The expression and regulation of Wnt16 in primary murine cells were studied by qPCR, scRNAseq and in situ hybridization. Signaling pathways were studied by siRNA silencing. The importance of oncostatin M (OSM)-induced WNT16 expression for osteoclastogenesis was studied in cells from Wnt16-deficient and wild-type mice. RESULTS: We found that IL-6/sIL-6R and OSM induce the expression of Wnt16 in primary mouse calvarial osteoblasts, with OSM being the most robust stimulator. The induction of Wnt16 by OSM was dependent on gp130 and OSM receptor (OSMR), and downstream signaling by the SHC1/STAT3 pathway, but independent of ERK. Stimulation of the calvarial cells with OSM resulted in enhanced numbers of mature, oversized osteoclasts when cells were isolated from Wnt16 deficient mice compared to cells from wild-type mice. OSM did not affect Wnt16 mRNA expression in bone marrow cell cultures, explained by the finding that Wnt16 and Osmr are expressed in distinctly different cells in bone marrow, nor was osteoclast differentiation different in OSM-stimulated bone marrow cell cultures isolated from Wnt16(−/-) or wild-type mice. Furthermore, we found that Wnt16 expression is substantially lower in cells from bone marrow compared to calvarial osteoblasts. CONCLUSION: These findings demonstrate that OSM is a robust stimulator of Wnt16 mRNA in calvarial osteoblasts and that WNT16 acts as a negative feedback regulator of OSM-induced osteoclast formation in the calvarial bone cells, but not in the bone marrow. Dove 2021-09-18 /pmc/articles/PMC8457865/ /pubmed/34566421 http://dx.doi.org/10.2147/JIR.S323435 Text en © 2021 Henning et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Henning, Petra
Movérare-Skrtic, Sofia
Westerlund, Anna
Chaves de Souza, Pedro Paulo
Floriano-Marcelino, Thais
Nilsson, Karin H
El Shahawy, Maha
Ohlsson, Claes
Lerner, Ulf H
WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
title WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
title_full WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
title_fullStr WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
title_full_unstemmed WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
title_short WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
title_sort wnt16 is robustly increased by oncostatin m in mouse calvarial osteoblasts and acts as a negative feedback regulator of osteoclast formation induced by oncostatin m
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457865/
https://www.ncbi.nlm.nih.gov/pubmed/34566421
http://dx.doi.org/10.2147/JIR.S323435
work_keys_str_mv AT henningpetra wnt16isrobustlyincreasedbyoncostatinminmousecalvarialosteoblastsandactsasanegativefeedbackregulatorofosteoclastformationinducedbyoncostatinm
AT moverareskrticsofia wnt16isrobustlyincreasedbyoncostatinminmousecalvarialosteoblastsandactsasanegativefeedbackregulatorofosteoclastformationinducedbyoncostatinm
AT westerlundanna wnt16isrobustlyincreasedbyoncostatinminmousecalvarialosteoblastsandactsasanegativefeedbackregulatorofosteoclastformationinducedbyoncostatinm
AT chavesdesouzapedropaulo wnt16isrobustlyincreasedbyoncostatinminmousecalvarialosteoblastsandactsasanegativefeedbackregulatorofosteoclastformationinducedbyoncostatinm
AT florianomarcelinothais wnt16isrobustlyincreasedbyoncostatinminmousecalvarialosteoblastsandactsasanegativefeedbackregulatorofosteoclastformationinducedbyoncostatinm
AT nilssonkarinh wnt16isrobustlyincreasedbyoncostatinminmousecalvarialosteoblastsandactsasanegativefeedbackregulatorofosteoclastformationinducedbyoncostatinm
AT elshahawymaha wnt16isrobustlyincreasedbyoncostatinminmousecalvarialosteoblastsandactsasanegativefeedbackregulatorofosteoclastformationinducedbyoncostatinm
AT ohlssonclaes wnt16isrobustlyincreasedbyoncostatinminmousecalvarialosteoblastsandactsasanegativefeedbackregulatorofosteoclastformationinducedbyoncostatinm
AT lernerulfh wnt16isrobustlyincreasedbyoncostatinminmousecalvarialosteoblastsandactsasanegativefeedbackregulatorofosteoclastformationinducedbyoncostatinm